Chromatin Interaction and Histone Mark Signatures Associated With TBXT Expression in Metastatic Lung Cancer
Reuben M Yaa1,2,3, Brian M Schilder2,3, Rafael D Acemel4
1Randall Centre for Cell & Molecular Biophysics, King's College London, London, UK.
Genes, Chromosomes & Cancer
|March 18, 2025
Summary
This study reveals that specific DNA elements and transcription factors regulate TBXT expression in lung cancer cells, offering insights into cancer metastasis. Understanding these epigenetic interactions is key to targeting TBXT in metastatic cancers.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- TBXT, a T-box transcription factor, promotes epithelial-to-mesenchymal transition and metastasis in certain cancers.
- The epigenetic regulation of TBXT expression in lung cancer is not well understood.
Purpose of the Study:
- To investigate the epigenetic regulatory landscape of TBXT in lung cancer.
- To identify cis-regulatory elements and transcription factors associated with TBXT expression.
Main Methods:
- Utilized circularized chromosome capture combined with sequencing (4C-seq) to analyze chromatin interactions at TBXT loci in lung cancer cell lines.
- Integrated chromatin interaction data with histone modification profiles and performed motif analysis.
Main Results:
- Identified distinct patterns of potential cis-regulatory elements (pCREs) near the TBXT promoter, with higher enrichment in TBXT-expressing cells.
- Discovered two unique pCREs in TBXT-expressing cells enriched with H3K27ac, a marker of active enhancers.
- These pCREs contain binding sites for transcription factors implicated in cancer metastasis, including forkhead box, zinc finger, and musculoaponeurotic fibrosarcoma families.
Conclusions:
- Revealed active chromatin interactions influencing TBXT expression in lung cancer.
- Identified specific DNA elements and regulatory proteins potentially involved in TBXT-driven metastasis.
- Provides a foundation for understanding TBXT's role in the initiation and progression of metastatic lung cancers.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


